Vnitr Lek 2008, 54(5):488-493

Epidemiology of diabetic nephropathy

I. Rychlík
Diabetologické centrum II. interní kliniky 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Michal Anděl, CSc.

The epidemiology of diabetic nephropathy (DN) should be approached from two angles: a) incidence of diabetic nephropathy in patients with diabetes, and b) epidemiology of chronic renal failure (CHRF) in diabetic patients. According to data from different sources, DN affects, in all its stages, about one third of patients irrespective of the type of diabetes they suffer from, with the peak rate of incidence after 15 years of duration of the illness. It is estimated that the rate of DN prevalence is 4-8% of patients monitored in diabetes centres. In addition, a significant portion of diabetics, especially the type 2 diabetic patients, are affected by the non-diabetic type nephropathy of primarily atherosclerotic etiology. Currently, DN is the principal cause of CHRF in advanced industrial countries (Western Europe, USA, Japan). A similar trend has been recorded in the Czech Republic which has one of the highest incidences of DN among the former Eastern Block countries. Most affected patients are type 2 diabetes patients. The cause of the above increase is the growing prevalence and incidence of type 2 diabetes, and, primarily, better care for type 2 diabetes patients who live long enough to develop severe macro and microvascular complications including DN. The principal factors influencing the risk of a diabetic patient developing DN are long-term monitoring of glycaemia, control of hypertension, genetic (ethnic) factors, age and sex. Metabolic control has an effect on the risk of diabetic nephropathy developing in type 1 and 2 diabetes, yet it is blood pressure control which is critical for the progression of chronic renal insufficiency in DN patients. In view of the high number of diabetic patients with CHRF which, in addition, associates with their high polymorbidity and extensive demands put on medical and nursing care which is not directly associated with CHRF therapy, we have to do with a serious medical and economic problem.

Keywords: diabetes mellitus; diabetic nephropathy; chronic renal failure; regular dialysis therapy

Received: April 8, 2008; Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rychlík I. Epidemiology of diabetic nephropathy. Vnitr Lek. 2008;54(5):488-493.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rychlík I, Miltenberger-Miltenyi G, Ritz E. The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. Nephrol Dial Transplant 1998; 13(Suppl 8): 6-10. Go to original source... Go to PubMed...
    2. Ritz E, Rychlík I, Locatelli F et al. End-stage renal failure in type 2 diabetes - a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34: 795-808. Go to original source... Go to PubMed...
    3. Rychlík I, Berdych M. Epidemiologie diabetické nefropatie. In: Rychlík I, Tesař V (eds). Onemocnění ledvin u diabetes mellitus. Praha: Tigis 2004: 127-138.
    4. Orchard TJ, Dorman JS, Maser RE et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990; 39: 1116. Go to original source... Go to PubMed...
    5. Parving HH, Hommel E, Mathiesen E et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J 1988; 296: 156. Go to original source... Go to PubMed...
    6. Bojestig M, Arnqvist HJ, Hermansson G et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15. Go to original source... Go to PubMed...
    7. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996; 50: 2041. Go to original source... Go to PubMed...
    8. Matsushima M, Tajima N, LaPorte RE et al. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 1995; 38: 236. Go to original source... Go to PubMed...
    9. Cowie CC, Port FK, Wolfe RA et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074. Go to original source... Go to PubMed...
    10. Pavkov ME, Knowler WC, Bennett PH et al. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int 2006; 70: 1840. Go to original source... Go to PubMed...
    11. Adler AI, Stevens RJ, Manley SE et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225. Go to original source... Go to PubMed...
    12. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341: 1127. Go to original source... Go to PubMed...
    13. Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996; 27: 167. Go to original source... Go to PubMed...
    14. Ballard DJ, Humphrey LL, Melton LJ et al. Epidemiology of persistent proteinuria in typus II diabetes mellitus. Population-based study in Orchester, Minnesota. Diabetes 1988; 37: 405-412. Go to original source... Go to PubMed...
    15. Rychlík I, Ritz E, Halimi S et al. Epidemiology of endstage renal disease in type 2 diabetes. In: Ritz E, Rychlík I (eds). Nephropathy in type 2 Diabetes. Oxford: Oxford University Press 1999: 246-266. Go to original source...
    16. Ghavamian M, Gutch CF, Kopp KF et al. The sad truth of hemodialysis in diabetic nephropathy. JAMA 1972; 222: 1386-1389. Go to original source...
    17. Raine AEG (on behalf of the EDTA Registry). Epidemiology, development and treatment of end stage renal failure in non insulin dependent diabetics in Europe. Diabetologia 1993; 36: 1099-1104. Go to original source... Go to PubMed...
    18. Renal Data System, USRDS 1999 Annual Data Report. Bethseda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2000.
    19. Ramsteijn PG, de Charro FT, Geerling W et al. 1998 Registratie nierfunctievervanging Nederland. Stichfing RENINE. Rotterdam: Statistisch Verlag 1998.
    20. Rodríguéz JA, Clèries M, Vela E and Renal Registry Committee. Diabetic patients on renal replacement therapy: analysis of Catalan. Nephrol Dial Transplant 1997; 12: 2501-2509. Go to original source... Go to PubMed...
    21. Ismail N, Becker BN, Strzelczyk P et al. Renal Disease and Hypertension in Non-Insulin-Dependent Diabetes Mellitus (editorial). Kidney Int 1999; 55: 1-28. Go to original source...
    22. Rychlík I. Epidemiologie diabetické nefropatie. In: Perušičová J (ed). Trendy soudobé diabetologie. Praha: Galén 2003. Vol. 7: 15-23.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.